Table 2. Effects of covariates on cerebral blood flow.
Model A |
Model B |
|||||
---|---|---|---|---|---|---|
Regression coefficient | 95% Confidence interval | P value | Regression coefficient | 95% Confidence interval | P value | |
PETCO2 (kPa) | 9.91% | 6.24%, 13.72% | <0.001 | 13.10% | 7.60%, 18.88% | <0.001 |
Gender (male) | −14.14% | 17.95%, −10.15% | <0.001 | −6.53% | −13.02%, 0.45% | 0.066 |
Hct (%) | — | — | — | −1.29% | −1.98%, −0.60% | <0.001 |
Study day #2 | −2.82% | −4.62%, −0.98% | 0.003 | −2.32% | −4.43%, −0.16% | 0.035 |
Study day #3 | 0.71% | −4.27%, 5.96% | 0.784 | −1.49% | −6.73%, 4.05% | 0.591 |
Measurement #2 | 2.42% | 0.59%, 4.27% | 0.009 | 2.78% | 0.43%, 5.17% | 0.020 |
Measurement #3 | −0.27% | −2.36%, 1.87% | 0.804 | 0.02% | −2.42%, 2.52% | 0.989 |
Intercept (mL/100 g per minute)a | 52.82 | 50.69, 55.03 | — | 50.74 | 47.68, 54.00 | — |
Abbreviations: CBF, cerebral blood flow; Hct, hematocrit; PETCO2, end-tidal expiratory PCO2.
All regression coefficients (except the intercept) are reported as % change in CBF per unit change in covariate.
Baseline CBF at study day #1 in males and at mean PETCO2 and Hct.